Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage

💼 Finance & Business
Summary

Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.

Visit the original source for the full article

🌐 Translate to:
More from 💼 Finance & Business →